Tag : Psychedelic

CCT Impact

Goodness Growth Holdings™ Subsidiary Resurgent Biosciences Launches First IRB-Approved Research Study on Entheogens & Psychedelic Experiences

CCT IMPACT Agent
Goodness Growth Holdings, Inc. (“Goodness Growth” or the “Company”) (CSE: GDNS; OTCQX: GDNSF), a physician-led, science-focused cannabis company and IP incubator, today announced that its subsidiary, Resurgent Biosciences, Inc. (“Resurgent”), is actively recruiting 100 participants to take part in an anonymous online survey to research the varying effects of entheogen and psychedelic......
CCT Impact

Chris Ryan PhD., New York Times Best Selling Author, and Featured TED Talk Speaker To Appear At Meet Delic: The World’s Premiere Psychedelic and Wellness Event

CCT IMPACT Agent
Delic Holdings Corp (“Delic” or the “Company”) (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), the leading psychedelic wellness platform, today announced that Chris Ryan Ph.D. will serve as one of the headline speakers at Meet Delic on November 7. Ryan is the New York Times best-selling co-author of, Sex at Dawn: How We Mate, Why We Stray, and What......
CCT Impact

Delic Announces Medical Advisory Board, Demonstrates Psychedelic Wellness Company’s Commitment to Science

CCT IMPACT Agent
Delic Holdings Corp (“Delic” or the “Company“) (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform today announced the formation of a Medical Advisory Board. The diverse advisory board consists of MDs, PhDs and others who specialize in psychedelic wellness and addition. The Board will advise Delic and its subsidiaries, including Ketamine......
CCT Impact

Delic Announces Ifetayo Harvey–Drug Reform Advocate and Founder and Board President of the People of Color Psychedelic Collective–to Speak at Meet Delic: The World’s Premiere Psychedelic and Wellness Event

CCT IMPACT Agent
Delic Holdings Inc. (“DELIC” or the “Company”) (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, today announced that Ifetayo Harvey will serve as one of the event’s mainstage speakers. Meet Delic is the world’s premiere psychedelic and wellness edutainment event catering to both curious newcomers, businesses and thought leaders. Harvey is the Founder and Board......
CCT Impact

Meet DELIC, the Premiere Psychedelic and Wellness Edutainment Event and Expo for Newcomers and Veteran Psychonauts, Announces Initial Business Speaker Lineup

CCT IMPACT Agent
Delic Holdings Inc. (“DELIC” or the “Company“) (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform today announced its initial list of business speakers and panelists to take part in Meet DELIC, the world’s premiere psychedelic and wellness edutainment event catering to both curious newcomers, businesses and thought leaders. The experiential event......
CCT Impact

Leading Psychedelic Wellness Company Delic Completes Acquisition of Ketamine Infusion Centers LLC, Adding Health Clinic Chain to Portfolio

CCT IMPACT Agent
Delic Holdings, Inc. (“DELIC” or the “Company“) (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform has completed its acquisition (the “Acquisition“) of Ketamine Infusion Centers LLC (“KIC“). KIC is a limited liability corporation formed under the laws of Arizona, which owns and operates two ketamine infusion treatment clinics, one in Phoenix, Arizona and......
CCT Impact

Leading Psychedelic Wellness Platform, Delic, Completes Acquisition of Complex Biotech Discovery Ventures Ltd.

CCT IMPACT Agent
Delic Holdings Inc. (“DELIC” or the “Company“) (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness platform, is pleased to announce that it has acquired all of the issued and outstanding shares in the capital of Complex Biotech Discovery Ventures Ltd. (“CBDV“), a federally-authorized psilocybin and cannabis research laboratory focused on extraction, analytical testing, and......
CCT Impact

Psychedelic Wellness-Focused Company Delic to Acquire Ketamine Infusion Centers LLC

CCT IMPACT Agent
Delic Holdings Inc. (“DELIC” or the “Company“) (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness-focused company, is pleased to announce it has entered into a binding letter agreement (the “Letter Agreement“) to acquire Ketamine Infusion Centers LLC (“KIC“). KIC is a limited liability corporation formed under the laws of Arizona, which owns and......
CCT Impact

MINDCURE Included in First Psychedelic ETF & North American Psychedelics Index

CCT IMPACT Agent
Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) (“MINDCURE” or the “Company”) is pleased to announce its inclusion among 17 psychedelic companies in the first ever Psychedelic ETF. Horizon’s Psychedelic ETF, is expected to commence trading Jan. 26, 2021 under ticker PSYK on the NEO exchange. The ETF includes companies in the Canadian......
CCT Impact

North America Psychedelic Drugs Market Could Exceed $6.8 Billion By 2027

CCT IMPACT Agent
In the few places where cannabis is legal, it can be incredibly lucrative. In 2019, the nascent worldwide cannabis sector pumped out approximately $15 billion in sales. By 2024, that number is expected to triple. Not bad for an industry that, less than a decade ago, was entirely illegal almost everywhere on......